| Assessment of hypolipidaemic activity of three thiazolidin-4-ones in mice given high-fat diet and fructose GK Nampurath, SP Mathew, V Khanna, RT Zachariah, S Kanji, ... Chemico-biological interactions 171 (3), 363-368, 2008 | 62 | 2008 |
| Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat P Prakash, V Singh, M Jain, M Rana, V Khanna, MK Barthwal, M Dikshit European journal of pharmacology 727, 15-28, 2014 | 58 | 2014 |
| Curcuma oil ameliorates hyperlipidaemia and associated deleterious effects in golden Syrian hamsters V Singh, M Jain, A Misra, V Khanna, M Rana, P Prakash, R Malasoni, ... British journal of nutrition 110 (3), 437-446, 2013 | 56 | 2013 |
| Atorvastatin protects against ischemia-reperfusion injury in fructose-induced insulin resistant rats P Prakash, V Khanna, V Singh, A Jyoti, M Jain, RS Keshari, MK Barthwal, ... Cardiovascular drugs and therapy 25, 285-297, 2011 | 40 | 2011 |
| Cholesterol diet withdrawal leads to an initial plaque instability and subsequent regression of accelerated iliac artery atherosclerosis in rabbits V Khanna, M Jain, V Singh, JS Kanshana, P Prakash, MK Barthwal, ... PloS one 8 (10), e77037, 2013 | 31 | 2013 |
| Curcuma oil reduces endothelial cell-mediated inflammation in postmyocardial ischemia/reperfusion in rats A Manhas, V Khanna, P Prakash, D Goyal, R Malasoni, A Naqvi, ... Journal of cardiovascular pharmacology 64 (3), 228-236, 2014 | 30 | 2014 |
| Antithrombotic Activity of a Newly Synthesized Coumarin Derivative 3‐(5‐Hydroxy‐2, 2‐dimethyl‐chroman‐6‐yl)‐N‐{2‐[3‐(5‐hydroxy‐2, 2‐dimethyl‐chroman‐6‐yl)‐propionylamino]‐ethyl … M Jain, WR Surin, A Misra, P Prakash, V Singh, V Khanna, S Kumar, ... Chemical biology & drug design 81 (4), 499-508, 2013 | 30 | 2013 |
| Vasomodulatory effect of novel peroxovanadate compounds on rat aorta: role of rho kinase and nitric oxide/cGMP pathway V Khanna, M Jain, MK Barthwal, D Kalita, JJ Boruah, SP Das, NS Islam, ... Pharmacological Research 64 (3), 274-282, 2011 | 30 | 2011 |
| Curcuma oil ameliorates insulin resistance & associated thrombotic complications in hamster & rat V Singh, M Jain, A Misra, V Khanna, P Prakash, R Malasoni, AK Dwivedi, ... Indian journal of medical research 141 (6), 823-832, 2015 | 24 | 2015 |
| Topiramate and type 2 diabetes: an old wine in a new bottle V Khanna, S Arumugam, S Roy, S Mittra, VS Bansal Expert Opinion on Therapeutic Targets 12 (1), 81-90, 2008 | 22 | 2008 |
| Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice S Roy, V Khanna, S Mittra, A Dhar, S Singh, DC Mahajan, P Priyadarsiny, ... Life sciences 81 (1), 72-79, 2007 | 21 | 2007 |
| RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes S Singh, S Sethi, V Khanna, B Benjamin, R Kant, J Sattigeri, VS Bansal, ... European journal of pharmacology 652 (1-3), 157-163, 2011 | 20 | 2011 |
| A time course study on prothrombotic parameters and their modulation by anti-platelet drugs in hyperlipidemic hamsters V Singh, M Jain, P Prakash, A Misra, V Khanna, RL Tiwari, RS Keshari, ... Journal of physiology and biochemistry 67, 205-216, 2011 | 12 | 2011 |
| Standardized fraction of Xylocarpus moluccensis fruits improve vascular relaxation and plaque stability in dyslipidemic models of atherosclerosis JS Kanshana, SC Rebello, P Pathak, BN Kanuri, H Aggarwal, ... Journal of ethnopharmacology 213, 81-91, 2018 | 11 | 2018 |
| Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin JS Kanshana, V Khanna, V Singh, M Jain, A Misra, S Kumar, M Farooqui, ... Journal of cardiovascular pharmacology 69 (5), 314-325, 2017 | 10 | 2017 |
| Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model JA Davis, PS Kumar, S Singh, A Surender, S Roy, V Khanna, S Sethi, ... Indian Journal of Pharmacology 44 (6), 759-764, 2012 | 3 | 2012 |
| Chiral 1-(4-methylphenylmethyl)-5-OXO-{N-[3-T-butoxycarbonyl-aminomethyl)]-piperidin-1-yl-pyrrolidine-2-carboxamides as inhibitors of collagen induced platelet activation and … DK Dikshit, M Dikshit, TI Siddiqui, A Kumar, RS Bhatta, GK Jain, ... US Patent 9,206,155, 2015 | 1 | 2015 |
| Chiral 1-(4-methylphenylmethyl)-5-oxo-{N-[(3-t-butoxycarbonyl-aminomethyl)]-piperidin-1-yl)-pyrrolidine as inhibitors of collagen induced platelet activation and adhesion DK Dikshit, M Dikshit, TI Siddiqui, A Kumar, RS Bhatta, GK Jain, ... US Patent 9,687,480, 2017 | | 2017 |
